New Weight Loss Study Finds Zepbound Outperforms Ozempic & Wegovy

REUTERS/Brendan McDermid/File Photo

Ally Reid

Tuesday, July 9th, 2024 10:46am

A new weight loss study has found that drug brands Zepbound and Mounjaro led to more weight loss compared to Ozempic and Wegovy. The active ingredient in Zepbound and Mounjaro is tirzepatide, while the active ingredient in Ozempic and Wegovy is semaglutide. This new study published by JAMA Internal Medicine found patients taking the highest Zepbound dose lost about 21% of their body weight during a 72-week period. Meanwhile, patients on the highest dose of Wegovy lost around 15% of their body weight during a 68-week period. Do you or anyone you know take any of the new weight loss drugs? What has been your or their experience with them?

Latest Posts

What's Happening

  • Come Work with Us

    We're hiring!

  • Herzog Law Firm

    Listen Saturday mornings from 8am-830am for The Estate and Medicaid Planning Hour with Herzog Law Firm.

  • Madison Wealth Managers

    Join Madison Wealth Managers for the ‘Planning for Prosperity Show’ Saturday mornings from 10am-11am on Magic 590 & 100.5.

Events

  • Rockin' On The River

    Don't miss the 2025 Rockin’ on the River in Troy! The free, family friendly concert series featuring four Wednesday nights of music in Riverfront Park along th...

    at Riverfront Park
  • Alive at 5

    Join the Capital Region music fans at Tricentennial Park, located on Broadway in Downtown Albany for the popular Thursday night summer concert series Alive at 5...

    at Tricentennial Park
  • Cohoes Rock the Block

    Don't miss 2025 Rock the Block concert Series in Cohoes! This FREE 8 week concert series is held Thursday evenings from 6:30p.m.-8:30p.m. in Canal Square (72 R...

    at Canal Square
100.5 FM & 590AM
Online
Mobile
Alexa